Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ellenberger

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Mutation Research|August 1, 1975
Mutagenicity studies in microorganisms in vitro, with extracts of mammalian organs, and with the host-mediated-assayG Mohn, J Ellenberger, D McGregor, et al.
Journal of Physics E: Scientific Instruments|September 1, 1976
Construction and performance of a cone-and-plate rheogoniometer with air bearingsJ Ellenberger, P J Klijn, M Tels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993
Recruiting memory B cells with changed antigenic specificityJ Ellenberger, G Creadon, X Zhang, et al.
AAPS Pharmscitech|May 31, 2018
Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a ReviewDaniel J Ellenberger, Dave A Miller, Robert O Williams
Die Naturwissenschaften|January 11, 2000
Utilisation of bubble resonance phenomena to improve gas-liquid contactR Krishna, J Ellenberger, M I Urseanu, et al.
AAPS Pharmscitech|March 16, 2018
Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® ProcessingDaniel J Ellenberger, Dave A Miller, Sandra U Kucera, et al.
Arzneimittel-Forschung|March 1, 1986
Safety assessment of brotizolamC Hewett, J Ellenberger, H Köllmer, et al.
AAPS Pharmscitech|June 6, 2018
Generation of a Weakly Acidic Amorphous Solid Dispersion of the Weak Base Ritonavir with Equivalent In Vitro and In Vivo Performance to Norvir TabletDaniel J Ellenberger, Dave A Miller, Sandra U Kucera, et al.
Molecular Pharmaceutics|June 11, 2020
<i>In Vitro</i> and <i>In Vivo</i> Behaviors of KinetiSol and Spray-Dried Amorphous Solid Dispersions of a Weakly Basic Drug and Ionic Polymer†Scott V Jermain, Michael B Lowinger, Daniel J Ellenberger, et al.
The Journal of Pharmacy and Pharmacology|October 11, 2015
Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavirDave A Miller, Justin M Keen, Chris Brough, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Mutation Research|August 1, 1975
Mutagenicity studies in microorganisms in vitro, with extracts of mammalian organs, and with the host-mediated-assayG Mohn, J Ellenberger, D McGregor, et al.
Journal of Physics E: Scientific Instruments|September 1, 1976
Construction and performance of a cone-and-plate rheogoniometer with air bearingsJ Ellenberger, P J Klijn, M Tels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993
Recruiting memory B cells with changed antigenic specificityJ Ellenberger, G Creadon, X Zhang, et al.
AAPS Pharmscitech|May 31, 2018
Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a ReviewDaniel J Ellenberger, Dave A Miller, Robert O Williams
Die Naturwissenschaften|January 11, 2000
Utilisation of bubble resonance phenomena to improve gas-liquid contactR Krishna, J Ellenberger, M I Urseanu, et al.
AAPS Pharmscitech|March 16, 2018
Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® ProcessingDaniel J Ellenberger, Dave A Miller, Sandra U Kucera, et al.
Arzneimittel-Forschung|March 1, 1986
Safety assessment of brotizolamC Hewett, J Ellenberger, H Köllmer, et al.
AAPS Pharmscitech|June 6, 2018
Generation of a Weakly Acidic Amorphous Solid Dispersion of the Weak Base Ritonavir with Equivalent In Vitro and In Vivo Performance to Norvir TabletDaniel J Ellenberger, Dave A Miller, Sandra U Kucera, et al.
Molecular Pharmaceutics|June 11, 2020
<i>In Vitro</i> and <i>In Vivo</i> Behaviors of KinetiSol and Spray-Dried Amorphous Solid Dispersions of a Weakly Basic Drug and Ionic Polymer†Scott V Jermain, Michael B Lowinger, Daniel J Ellenberger, et al.
The Journal of Pharmacy and Pharmacology|October 11, 2015
Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavirDave A Miller, Justin M Keen, Chris Brough, et al.
Pageof 3